Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster Headache

Rashmi B. Halker Singh, Jessica Ailani, Matthew S. Robbins

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Headache disorders are among the most common and disabling medical conditions worldwide. Pharmacologic acute and preventive treatments are often insufficient and poorly tolerated, and the majority of patients are unable to adhere to their migraine treatments due to these issues. With improvements in our understanding of migraine and cluster headache pathophysiology, neuromodulation devices have been developed as safe and effective acute and preventive treatment options. In this review, we focus on neuromodulation devices that have been studied for migraine and cluster headache, with special attention to those that have gained food and drug administration (FDA) clearance. We will also explore how these devices can be used in patients who might have limited pharmacologic options, including the elderly, children, and pregnant women.

Original languageEnglish (US)
Pages (from-to)33-49
Number of pages17
JournalHeadache
Volume59
Issue numberS2
DOIs
StatePublished - Jul 1 2019

Fingerprint

Cluster Headache
Migraine Disorders
Equipment and Supplies
Headache Disorders
United States Food and Drug Administration
Pregnant Women
Therapeutics

Keywords

  • cluster headache
  • migraine acute treatment
  • migraine prevention
  • neuromodulation
  • neurostimulation

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster Headache. / Halker Singh, Rashmi B.; Ailani, Jessica; Robbins, Matthew S.

In: Headache, Vol. 59, No. S2, 01.07.2019, p. 33-49.

Research output: Contribution to journalReview article

Halker Singh, Rashmi B. ; Ailani, Jessica ; Robbins, Matthew S. / Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster Headache. In: Headache. 2019 ; Vol. 59, No. S2. pp. 33-49.
@article{9bdc34eca1914e80bd85e2161e4049a5,
title = "Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster Headache",
abstract = "Headache disorders are among the most common and disabling medical conditions worldwide. Pharmacologic acute and preventive treatments are often insufficient and poorly tolerated, and the majority of patients are unable to adhere to their migraine treatments due to these issues. With improvements in our understanding of migraine and cluster headache pathophysiology, neuromodulation devices have been developed as safe and effective acute and preventive treatment options. In this review, we focus on neuromodulation devices that have been studied for migraine and cluster headache, with special attention to those that have gained food and drug administration (FDA) clearance. We will also explore how these devices can be used in patients who might have limited pharmacologic options, including the elderly, children, and pregnant women.",
keywords = "cluster headache, migraine acute treatment, migraine prevention, neuromodulation, neurostimulation",
author = "{Halker Singh}, {Rashmi B.} and Jessica Ailani and Robbins, {Matthew S.}",
year = "2019",
month = "7",
day = "1",
doi = "10.1111/head.13586",
language = "English (US)",
volume = "59",
pages = "33--49",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "S2",

}

TY - JOUR

T1 - Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster Headache

AU - Halker Singh, Rashmi B.

AU - Ailani, Jessica

AU - Robbins, Matthew S.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Headache disorders are among the most common and disabling medical conditions worldwide. Pharmacologic acute and preventive treatments are often insufficient and poorly tolerated, and the majority of patients are unable to adhere to their migraine treatments due to these issues. With improvements in our understanding of migraine and cluster headache pathophysiology, neuromodulation devices have been developed as safe and effective acute and preventive treatment options. In this review, we focus on neuromodulation devices that have been studied for migraine and cluster headache, with special attention to those that have gained food and drug administration (FDA) clearance. We will also explore how these devices can be used in patients who might have limited pharmacologic options, including the elderly, children, and pregnant women.

AB - Headache disorders are among the most common and disabling medical conditions worldwide. Pharmacologic acute and preventive treatments are often insufficient and poorly tolerated, and the majority of patients are unable to adhere to their migraine treatments due to these issues. With improvements in our understanding of migraine and cluster headache pathophysiology, neuromodulation devices have been developed as safe and effective acute and preventive treatment options. In this review, we focus on neuromodulation devices that have been studied for migraine and cluster headache, with special attention to those that have gained food and drug administration (FDA) clearance. We will also explore how these devices can be used in patients who might have limited pharmacologic options, including the elderly, children, and pregnant women.

KW - cluster headache

KW - migraine acute treatment

KW - migraine prevention

KW - neuromodulation

KW - neurostimulation

UR - http://www.scopus.com/inward/record.url?scp=85068833122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068833122&partnerID=8YFLogxK

U2 - 10.1111/head.13586

DO - 10.1111/head.13586

M3 - Review article

C2 - 31291017

AN - SCOPUS:85068833122

VL - 59

SP - 33

EP - 49

JO - Headache

JF - Headache

SN - 0017-8748

IS - S2

ER -